• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Falls 150 Points; AutoZone Earnings Top Views

    9/19/23 2:32:23 PM ET
    $AVGR
    $AZO
    $ELUT
    $HSTO
    Medical/Dental Instruments
    Health Care
    Auto & Home Supply Stores
    Consumer Discretionary
    Get the next $AVGR alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday.

    The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P 500 also fell, dropping, 0.34% to 4,438.52.

    Check This Out: Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday

     

    Leading and Lagging Sectors

    Communication services shares fell by just 0.02% on Tuesday.

    In trading on Tuesday, energy shares dipped by 1.1%.

     

    Top Headline

    AutoZone Inc (NYSE:AZO) reported better-than-expected earnings for its fourth quarter.

    The company posted fourth-quarter FY23 sales growth of 6.4% year-on-year to $5.69 billion, beating the analyst consensus of $5.61 billion. EPS of $46.46 beat the consensus of $45.12.

     

    Equities Trading UP

    Rackspace Technology, Inc. (NASDAQ:RXT) shares shot up 36% to $2.0102 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $3.5 price target.

    Shares of Avinger, Inc. (NASDAQ:AVGR) got a boost, shooting 41% to $8.53, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.

    Elutia Inc. (NASDAQ:ELUT) shares were also up, gaining 29% to $1.6050 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.

     

    Equities Trading DOWN

    60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) shares dropped 19% to $0.8950. 60 Degrees Pharmaceuticals’ subsidiary, 60P Australia Pty Ltd, has withdrawn its investigational new drug (IND) application for ACLR8-LR, a Phase 2B study of the use of tafenoquine in treating COVID-19.

    Shares of Histogen Inc. (NASDAQ:HSTO) were down 33% to $0.4401 as the company reported board approval of complete liquidation and dissolution.

    Revance Therapeutics, Inc. (NASDAQ:RVNC) was down, falling 21% to $13.20. Revance Therapeutics commenced a plan to exit the OPUL payments business, citing that significant costs and resources required to support OPUL no longer align with the company’s capital allocation priorities.

    Also Check This Out: Ocean Power Technologies And 3 Other Stocks Under $1 Insiders Are Buying

     

    Commodities

    In commodity news, oil traded up 0.1% to $91.52 while gold traded down 0.1% at $1,951.80.

    Silver traded down 0.2% to $23.46 on Tuesday while copper fell 0.7% to $3.7520.

     

    Euro zone

    European shares closed mixed today. The eurozone’s STOXX 600 fell 0.04% London’s FTSE 100 rose 0.09% while Spain’s IBEX 35 Index rose 0.48% The German DAX fell 0.40% French CAC 40 rose 0.08%, while Italy’s FTSE MIB Index gained 0.60%.

    Annual inflation rate in the Eurozone was revised lower to 5.2% in August versus an initial reading of 5.3%, recording the lowest reading since Jan. 2022. The Eurozone posted a current account surplus of €26.9 billion in July versus a €15.8 billion deficit in the year-ago month.

    Italy's current account surplus widened to EUR 5.156 billion in July from EUR 0.795 billion in the year-ago month.

     

    Asia Pacific Markets

    Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.87%, Hong Kong’s Hang Seng Index rising 0.37% and China’s Shanghai Composite Index falling 0.03%.

    Hong Kong's unemployment rate came in unchanged at 2.8% during the three months ending Aug. 2023.

     

    Economics

    The FOMC starts its two-day policy meeting today.

    Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020.

    Building permits rose 6.9% to an annual rate of 1.543 million in August, notching the highest level in 10 months.

    Now Read This: Top 5 Energy Stocks That You May Want To Dump In September

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,479,200 cases with around 1,175,350 deaths. India confirmed a total of at least 44,998,210 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,437,400 cases of COVID-19 worldwide with more than 6,916,330 deaths.

    Get the next $AVGR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVGR
    $AZO
    $ELUT
    $HSTO

    CompanyDatePrice TargetRatingAnalyst
    AutoZone Inc.
    $AZO
    2/9/2026$3900.00Outperform → Neutral
    Robert W. Baird
    AutoZone Inc.
    $AZO
    1/5/2026$3550.00Outperform → Neutral
    Mizuho
    AutoZone Inc.
    $AZO
    12/18/2025$4850.00 → $4100.00Overweight
    Analyst
    AutoZone Inc.
    $AZO
    12/16/2025Outperform → Peer Perform
    Wolfe Research
    AutoZone Inc.
    $AZO
    12/4/2025$4500.00Outperform
    Robert W. Baird
    AutoZone Inc.
    $AZO
    11/13/2025$4262.00Neutral → Buy
    Goldman
    AutoZone Inc.
    $AZO
    10/31/2025Buy → Hold
    Erste Group
    AutoZone Inc.
    $AZO
    9/18/2025$4741.00Outperform
    Wolfe Research
    More analyst ratings

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rakin Kevin bought $74,200 worth of shares (70,000 units at $1.06), increasing direct ownership by 56% to 196,120 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 5:01:40 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $20,800 worth of shares (20,000 units at $1.04), increasing direct ownership by 20% to 118,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 8:43:47 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $31,800 worth of shares (30,000 units at $1.06), increasing direct ownership by 44% to 98,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    1/29/26 5:51:15 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Elutia Inc.

    SCHEDULE 13G/A - ELUTIA INC. (0001708527) (Subject)

    1/28/26 2:17:08 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    60 Degrees Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure

    8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer)

    1/23/26 5:20:24 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    60 Degrees Pharmaceuticals Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Filer)

    1/21/26 4:05:27 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AutoZone to Release Second Quarter Fiscal 2026 Earnings March 3, 2026

    MEMPHIS, Tenn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE:AZO), the leading retailer and distributor of automotive replacement parts and accessories in the Americas, will release results for its second quarter ended Saturday, February 14, 2026, before market open on Tuesday, March 3, 2026. Additionally, the Company will host a one-hour conference call on Tuesday, March 3, 2026, beginning at 10:00 a.m. (ET), to discuss the results of the quarter. This call is being webcast and can be accessed, along with supporting slides, at AutoZone's website at www.autozone.com and by clicking on Investor Relations. Investors may also listen to the call by dialing (888) 506-0062, passcode AU

    2/10/26 5:00:00 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Rackspace Technology to Announce Fourth Quarter 2025 Earnings on February 26, 2026

    SAN ANTONIO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its fourth quarter 2025 financial results at 8 am ET on Thursday, February 26, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (February 26, 2026) at 8:30 am ET to discuss the Company's financial results. Interested parties may access the conference call as follows: To listen to the live webcast or access the replay following the webcast, please visit our IR website at the following link: https://ir.rackspace.com/news-a

    2/10/26 4:06:00 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

    GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed to lower patient out-of-pocket costs and expand the reach of Company's marketing strategyPartnership will improve the affordability of ARAKODA at over 70,000 pharmacies nationwide for people planning travel to malaria-endemic regions WASHINGTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP, SXTPW)) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced a partnership with GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., to offer eligible co

    2/2/26 8:01:00 AM ET
    $GDRX
    $SXTP
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Rakin Kevin bought $74,200 worth of shares (70,000 units at $1.06), increasing direct ownership by 56% to 196,120 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 5:01:40 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $20,800 worth of shares (20,000 units at $1.04), increasing direct ownership by 20% to 118,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    2/2/26 8:43:47 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Neels Guido J bought $31,800 worth of shares (30,000 units at $1.06), increasing direct ownership by 44% to 98,750 units (SEC Form 4)

    4 - ELUTIA INC. (0001708527) (Issuer)

    1/29/26 5:51:15 PM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AVGR
    $AZO
    $ELUT
    $HSTO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    AutoZone downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded AutoZone from Outperform to Neutral and set a new price target of $3,900.00

    2/9/26 7:54:56 AM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    AutoZone downgraded by Mizuho with a new price target

    Mizuho downgraded AutoZone from Outperform to Neutral and set a new price target of $3,550.00

    1/5/26 8:45:41 AM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Analyst reiterated coverage on AutoZone with a new price target

    Analyst reiterated coverage of AutoZone with a rating of Overweight and set a new price target of $4,100.00 from $4,850.00 previously

    12/18/25 9:52:36 AM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (SUPPL-2) with active ingredient DAXIBOTULINUMTOXINA-LANM has changed to 'Approval' on 08/11/2023. Application Category: BLA, Application Number: 761127, Application Classification:

    8/14/23 4:38:56 AM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAXXIFY issued to REVANCE THERAPEUTICS, INC.

    Submission status for REVANCE THERAPEUTICS, INC.'s drug DAXXIFY (ORIG-1) with active ingredient daxibotulinumtoixnA-lanm has changed to 'Approval' on 09/07/2022. Application Category: BLA, Application Number: 761127, Application Classification:

    9/8/22 1:11:06 PM ET
    $RVNC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Rackspace Technology Inc.

    SC 13G/A - Rackspace Technology, Inc. (0001810019) (Subject)

    11/14/24 4:32:40 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by 60 Degrees Pharmaceuticals Inc.

    SC 13G - 60 DEGREES PHARMACEUTICALS, INC. (0001946563) (Subject)

    11/14/24 3:37:18 PM ET
    $SXTP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Avinger Inc.

    SC 13G - Avinger Inc (0001506928) (Subject)

    11/14/24 3:23:30 PM ET
    $AVGR
    Medical/Dental Instruments
    Health Care

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Financials

    Live finance-specific insights

    View All

    AutoZone to Release Second Quarter Fiscal 2026 Earnings March 3, 2026

    MEMPHIS, Tenn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE:AZO), the leading retailer and distributor of automotive replacement parts and accessories in the Americas, will release results for its second quarter ended Saturday, February 14, 2026, before market open on Tuesday, March 3, 2026. Additionally, the Company will host a one-hour conference call on Tuesday, March 3, 2026, beginning at 10:00 a.m. (ET), to discuss the results of the quarter. This call is being webcast and can be accessed, along with supporting slides, at AutoZone's website at www.autozone.com and by clicking on Investor Relations. Investors may also listen to the call by dialing (888) 506-0062, passcode AU

    2/10/26 5:00:00 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Rackspace Technology to Announce Fourth Quarter 2025 Earnings on February 26, 2026

    SAN ANTONIO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT) a leading end-to-end hybrid cloud and AI solutions company, today announced that it will release its fourth quarter 2025 financial results at 8 am ET on Thursday, February 26, 2026. Gajen Kandiah, Chief Executive Officer, and Mark Marino, Chief Financial Officer, will host a conference call on the day of the release (February 26, 2026) at 8:30 am ET to discuss the Company's financial results. Interested parties may access the conference call as follows: To listen to the live webcast or access the replay following the webcast, please visit our IR website at the following link: https://ir.rackspace.com/news-a

    2/10/26 4:06:00 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    AutoZone 1st Quarter Total Company Same Store Sales Increase 4.7%; Domestic Same Store Sales Increase 4.8%; 1st Quarter EPS of $31.04

    MEMPHIS, Tenn., Dec. 09, 2025 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE:AZO) today reported net sales of $4.6 billion for its first quarter (12 weeks) ended November 22, 2025, an increase of 8.2% from the first quarter of fiscal 2025 (12 weeks). Same store sales, or sales for our domestic and international stores open at least one year, are as follows:    Constant Currency 12 Weeks 12 Weeks*    Domestic4.8% 4.8%International11.2% 3.7%Total Company5.5% 4.7%* Excludes impacts from fluctuations of foreign exchange rates.        For the quarter, gross profit, as a percentage of sales, was 51.0%, a decrease of 203 basis points versus the prior year. The decrease in gross margin was driven by a 2

    12/9/25 6:55:00 AM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $AVGR
    $AZO
    $ELUT
    $HSTO
    Leadership Updates

    Live Leadership Updates

    View All

    Joseph Vito Joins Rackspace Technology to Lead Strategic Alliance Partnerships

    SAN ANTONIO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the appointment of Joseph Vito as Senior Vice President of Strategic Alliance Partnerships. In this role, Vito will lead Rackspace's global strategy for building and strengthening technology and channel partnerships that drive innovation and deliver exceptional value to customers. Vito brings more than 25 years of experience in technology leadership, cloud transformation, and enterprise solutions across financial services, life sciences, energy, and consumer manufacturing. Most recently, he served as a Strategic Transformation Princ

    1/27/26 8:15:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation

    SAN ANTONIO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid, multicloud, and AI solutions company, today announced the appointment of Lata Varghese as Senior Vice President of Business Transformation and Phani Kishore Burre, as Senior Vice President of Services and Delivery for the Public Cloud business unit. Lata Varghese brings extensive leadership experience in technology services, CXO advisory and business transformation. At Cognizant, she managed global P&L responsibilities and spearheaded the incubation and growth of emerging technology consulting practices. Her domain expertise spans financial services, digital banking, payments, b

    11/17/25 8:05:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

    Industry leader brings 40 years of executive and board experience across the global medical technology sector GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, announced the appointment of Guido J. Neels to the Company's Board of Directors. Mr. Neels will also serve as a member of the audit committee of the Board. In conjunction with Mr. Neels' appointment, W. Matthew Zuga and Maybelle Jordan have both stepped down as members of Elutia's Board. "Randy and I are excited to welcome Guido to our Board of Directors and the Elutia CRU," said Kevin Rakin, Executive Chairman of Elutia. "G

    10/10/25 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care